Literature DB >> 31820904

PEGylation of Paclitaxel-Loaded Cationic Liposomes Drives Steric Stabilization of Bicelles and Vesicles thereby Enhancing Delivery and Cytotoxicity to Human Cancer Cells.

Victoria M Steffes, Zhening Zhang1, Scott MacDonald, John Crowe, Kai K Ewert, Bridget Carragher1, Clinton S Potter1, Cyrus R Safinya.   

Abstract

Poly(ethylene glycol) (PEG) is a polymer used widely in drug delivery to create "stealth" nanoparticles (NPs); PEG coatings suppress NP detection and clearance by the immune system and beneficially increase NP circulation time in vivo. However, NP PEGylation typically obstructs cell attachment and uptake in vitro compared to the uncoated equivalent. Here, we report on a cationic liposome (CL) NP system loaded with the hydrophobic cancer drug paclitaxel (PTX) in which PEGylation (i.e., PEG-CLPTX NPs) unexpectedly enhances, rather than diminishes, delivery efficacy and cytotoxicity to human cancer cells. This highly unexpected enhancement occurs even when the PEG-chains coating the NP are in the transition regime between the mushroom and brush conformations. Cryogenic transmission electron microscopy (TEM) of PEG-CLPTX NPs shows that PEG causes the proliferation of a mixture of sterically stabilized nanometer-scale vesicles and anisotropic micelles (e.g., bicelles). Remarkably, the onset of bicelles at sub-monolayer concentrations of the PEG coat has to our knowledge not been previously reported; it was previously thought that PEG-lipid in this composition regime was incorporated into vesicles but did not alter their shape. Confocal microscopy and flow cytometry reveal significantly greater PTX cell uptake from stabilized PEG-CLPTX NPs (vesicles and bicelles) in contrast to bare CLPTX NPs, which can aggregate in cell medium. This underscores the ability of steric stabilization to facilitate NP entry into cells via distinct size-dependent endocytic pathways, some of which cannot transport large NP aggregates into cells. This study highlights the value of understanding how PEGylation alters NP shape and structure, and thus NP efficacy, to design next-generation stealth drug carriers that integrate active cell-targeting strategies into NPs for in vivo delivery.

Entities:  

Keywords:  PEGylation; bicelles; cationic liposomes; cryogenic electron microscopy; discoidal micelles; paclitaxel delivery

Mesh:

Substances:

Year:  2019        PMID: 31820904      PMCID: PMC6984750          DOI: 10.1021/acsami.9b16150

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  63 in total

1.  Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo.

Authors:  Swati Biswas; Namita S Dodwadkar; Pranali P Deshpande; Vladimir P Torchilin
Journal:  J Control Release       Date:  2012-01-20       Impact factor: 9.776

2.  Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.

Authors:  P Crosasso; M Ceruti; P Brusa; S Arpicco; F Dosio; L Cattel
Journal:  J Control Release       Date:  2000-01-03       Impact factor: 9.776

Review 3.  Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine.

Authors:  Calum Kinnear; Thomas L Moore; Laura Rodriguez-Lorenzo; Barbara Rothen-Rutishauser; Alke Petri-Fink
Journal:  Chem Rev       Date:  2017-09-01       Impact factor: 60.622

Review 4.  Paclitaxel in cancer therapy.

Authors:  Tarek M Mekhail; Maurie Markman
Journal:  Expert Opin Pharmacother       Date:  2002-06       Impact factor: 3.889

5.  Block Liposome and Nanotube Formation is a General Phenomenon of Two-Component Membranes Containing Multivalent Lipids.

Authors:  Alexandra Zidovska; Kai K Ewert; Joel Quispe; Bridget Carragher; Clinton S Potter; Cyrus R Safinya
Journal:  Soft Matter       Date:  2011-06-20       Impact factor: 3.679

6.  Interaction of the anticancer agent Taxol (paclitaxel) with phospholipid bilayers.

Authors:  C Bernsdorff; R Reszka; R Winter
Journal:  J Biomed Mater Res       Date:  1999-08

7.  Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.

Authors:  Martin E Eichhorn; Ivan Ischenko; Siiri Luedemann; Sebastian Strieth; Armine Papyan; Alexander Werner; Hermann Bohnenkamp; Eric Guenzi; Gerhard Preissler; Uwe Michaelis; Karl-Walter Jauch; Christiane J Bruns; Marc Dellian
Journal:  Int J Cancer       Date:  2010-03-01       Impact factor: 7.396

8.  Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.

Authors:  Sebastian Strieth; Martin E Eichhorn; Birgitta Sauer; Brita Schulze; Michael Teifel; Uwe Michaelis; Marc Dellian
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

Review 9.  Lipid membranes with grafted polymers: physicochemical aspects.

Authors:  Derek Marsh; Rosa Bartucci; Luigi Sportelli
Journal:  Biochim Biophys Acta       Date:  2003-09-02

10.  Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.

Authors:  Victoria M Steffes; Meena M Murali; Yoonsang Park; Bretton J Fletcher; Kai K Ewert; Cyrus R Safinya
Journal:  Biomaterials       Date:  2017-08-17       Impact factor: 12.479

View more
  5 in total

1.  Polyvinylpyrrolidone-Modified Taxifolin Liposomes Promote Liver Repair by Modulating Autophagy to Inhibit Activation of the TLR4/NF-κB Signaling Pathway.

Authors:  Qiteng Ding; Wencong Liu; Xinglong Liu; Chuanbo Ding; Yingchun Zhao; Ling Dong; Huiying Chen; Shuwen Sun; Yiwen Zhang; Jinping Zhang; Ming Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-06-01

2.  Assembly of Building Blocks by Double-End-Anchored Polymers in the Dilute Regime Mediated by Hydrophobic Interactions at Controlled Distances.

Authors:  Emily A Wonder; Kai K Ewert; Chenyu Liu; Victoria M Steffes; Jasmin Kwak; Vikar Qahar; Ramsey N Majzoub; Zhening Zhang; Bridget Carragher; Clinton S Potter; Youli Li; Weihong Qiao; Cyrus R Safinya
Journal:  ACS Appl Mater Interfaces       Date:  2020-10-05       Impact factor: 9.229

3.  Exosomes are secreted at similar densities by M21 and PC3 human cancer cells and show paclitaxel solubility.

Authors:  William S Fisher; Christine Tchounwou; Sophia Wei; Logan Roberts; Kai K Ewert; Cyrus R Safinya
Journal:  Biochim Biophys Acta Biomembr       Date:  2021-12-22       Impact factor: 3.747

4.  Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas.

Authors:  Dehua Kong; Wenyu Hong; Miao Yu; Yanxia Li; YaXin Zheng; Xue Ying
Journal:  Int J Nanomedicine       Date:  2022-03-14

Review 5.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.